RNLX - Why Is AI-Powered Diagnostic Firm Renalytix Stock Soaring On Monday? | Benzinga
Renalytix plc (NASDAQ:RNLX) has received an unsolicited acquisition approach from a large, publicly-listed strategic diagnostics company and is evaluating an acquisition of the entire issued, and to be issued, the share capital of the company.
Renalytix is an artificial intelligence-enabled diagnostics company focused on kidney disease.
The company’s lead product, KidneyIntelX, is a laboratory-developed test.
Renalytix’s stock is trading higher on an increased session volume of 9.26 million, compared to ...